REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas is an enterprise located in Colombia, with the main office in Monteria. The enterprise operates in the Ambulatory Health Care Services industry. It was incorporated on May 24, 2016. The company’s latest financial report indicates a net sales revenue increase of 52.8% in 2023. There was a total growth of 27.08% in Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas’s total assets over the same period. The net profit margin of Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas decreased by 3.96% in 2023.

Headquarters
Calle 74 Nro. 5 70 Urb. La Sevillana
Monteria; Cordoba;

Contact Details: Purchase the Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas report to view the information.
Incorporation Date:
May 24, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Enfermedades Digestivas Dr Abraham Ganem I.P.S Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
52.8%
Total operating revenue
52.8%
Operating profit (EBIT)
-3.01%
Net Profit (Loss) for the Period
-5.15%
Total assets
27.08%
Total equity
262.76%
Operating Profit Margin (ROS)
-4.21%
Net Profit Margin
-3.96%
Return on Equity (ROE)
-56.08%
Quick Ratio
1.21%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?